Suppr超能文献

欧洲老年患者和中年患者之间的癌症生存率差距正在扩大。

The cancer survival gap between elderly and middle-aged patients in Europe is widening.

作者信息

Quaglia Alberto, Tavilla Andrea, Shack Lorraine, Brenner Hermann, Janssen-Heijnen Maryska, Allemani Claudia, Colonna Marc, Grande Enrico, Grosclaude Pascale, Vercelli Marina

机构信息

Liguria Cancer Registry, National Cancer Research Institute, Genoa 16132, Italy.

出版信息

Eur J Cancer. 2009 Apr;45(6):1006-16. doi: 10.1016/j.ejca.2008.11.028. Epub 2008 Dec 31.

Abstract

The present study is aimed to compare survival and prognostic changes over time between elderly (70-84 years) and middle-aged cancer patients (55-69 years). We considered seven cancer sites (stomach, colon, breast, cervix and corpus uteri, ovary and prostate) and all cancers combined (but excluding prostate and non-melanoma skin cancers). Five-year relative survival was estimated for cohorts of patients diagnosed in 1988-1999 in a pool of 51 European populations covered by cancer registries. Furthermore, we applied the period-analysis method to more recent incidence data from 32 cancer registries to provide 1- and 5-year relative survival estimates for the period of follow-up 2000-2002. A significant survival improvement was observed from 1988 to 1999 for all cancers combined and for every cancer site, except cervical cancer. However, survival increased at a slower rate in the elderly, so that the gap between younger and older patients widened, particularly for prostate cancer in men and for all considered cancers except cervical cancer in women. For breast and prostate cancers, the increasing gap was likely attributable to a larger use of, respectively, mammographic screening and PSA test in middle-aged with respect to the elderly. In the period analysis of the most recent data, relative survival was much higher in middle-aged patients than in the elderly. The differences were higher for breast and gynaecological cancers, and for prostate cancer. Most of this age gap was due to a very large difference in survival after the 1st year following the diagnosis. Differences were much smaller for conditional 5-year relative survival among patients who had already survived the first year. The increase of survival in elderly men is encouraging but the lesser improvement in women and, in particular, the widening gap for breast cancer suggest that many barriers still delay access to care and that enhanced prevention and clinical management remain major issues.

摘要

本研究旨在比较老年(70 - 84岁)和中年癌症患者(55 - 69岁)随时间推移的生存率和预后变化。我们考虑了七个癌症部位(胃、结肠、乳腺、子宫颈和子宫体、卵巢和前列腺)以及所有癌症合并情况(但不包括前列腺癌和非黑色素瘤皮肤癌)。对癌症登记处覆盖的51个欧洲人群中1988 - 1999年诊断的患者队列估计了五年相对生存率。此外,我们将时期分析方法应用于32个癌症登记处的最新发病数据,以提供2000 - 2002年随访期的1年和5年相对生存率估计。从1988年到1999年,除宫颈癌外,所有癌症合并情况以及每个癌症部位的生存率均有显著提高。然而,老年人的生存率增长速度较慢,因此年轻患者和老年患者之间的差距扩大,特别是男性前列腺癌以及女性除宫颈癌外的所有考虑的癌症。对于乳腺癌和前列腺癌,差距扩大可能分别归因于中年人群相对于老年人群更多地使用了乳腺钼靶筛查和前列腺特异性抗原检测。在最新数据的时期分析中,中年患者的相对生存率远高于老年患者。乳腺癌、妇科癌症和前列腺癌的差异更大。这种年龄差距的大部分是由于诊断后第1年生存率的巨大差异。对于已经存活1年的患者,有条件的5年相对生存率差异要小得多。老年男性生存率的提高令人鼓舞,但女性改善较小,尤其是乳腺癌差距扩大,这表明许多障碍仍然阻碍着获得医疗服务,加强预防和临床管理仍然是主要问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验